DOCTOREYE X-EYE is an AI software solution that analyzes optical fundus images to detect the presence of ophthalmic diseases including age-related Macular degeneration, Diabetic retinopathy, Glaucoma, and Epiretinal membrane within seconds.
It supports clinical decision-making by healthcare professionals.
*Approval from the Ministry of Food and Drug Safety (No. D 26-1)
X-BRAIN analyzes optical fundus images to identify potential brain diseases and clinically significant findings, thereby supporting clinical decision-making by healthcare professionals.
*DOCTOREYE X-BRAIN is currently under research and development.
fundus Camera - RETVIEW100
AI software - DOCTOREYE series
*On device AI is currently under research and development.
Global Evidence Base
Fundus to EYE / Coronary Artery / Aneurysm
Non-mydriatic fundus imaging enables early detection of glaucoma.
Non-mydriatic fundus imaging enables early detection of glaucoma.
A single-field fundus photograph enables efficient diabetic retinopathy screening.
A single-field fundus photograph enables efficient diabetic retinopathy screening.
DOCTOREYE X-EYE is an AI software solution that analyzes optical fundus images to detect the presence of ophthalmic diseases including age-related Macular degeneration, Diabetic retinopathy, Glaucoma, and Epiretinal membrane within seconds.
It supports clinical decision-making by healthcare professionals.
*Approval from the Ministry of Food and Drug Safety (No. D 26-1)
X-BRAIN
Our AI-based system analyzes optical fundus images to identify potential brain diseases and clinically significant findings, thereby supporting clinical decision-making by healthcare professionals.
*DOCTOREYE X-BRAIN is currently under research and development.
On device AI
fundus Camera - RETVIEW100
AI software - DOCTOREYE series
*On device AI is currently under research and development.
Fundus to EYE / Coronary Artery stenosis / Aneurysm
Non-mydriatic fundus imaging enables
early detection of glaucoma
A single-field fundus photograph enables efficient diabetic retinopathy screening.
Fundus imaging detects subtle retinal
membrane changes
Predicting the Degree of Coronary Artery
Stenosis Through Retinal Vascular Characteristics
and Minimal Clinical Information
Optimizing retinal images based carotid atherosclerosis prediction with explainable foundation models
Integrating oculomics with genomics reveals imaging biomarkers for preventive and personalized prediction of arterial aneurysms
Pie healthcare : AI software
DOCTOR EYE | X-EYE
DOCTOREYE X-EYE is an AI software solution that analyzes optical fundus images to detect the presence of ophthalmic diseases including age-related Macular degeneration, Diabetic retinopathy, Glaucoma, and Epiretinal membrane within seconds.
By doing so, it supports clinical decision-making by healthcare professionals.
*Approval from the Ministry of Food and Drug Safety (No. D 26-1)
Key regions analyzed by the AI can be visualized through heat maps.
Diabetic
Diabetic
Diabetic heatmap
Diabetic heatmap
AMD
AMD
AMD heatmap
AMD heatmap
3.Report
To enable users to intuitively review examination results, the system provides the analysis results for easy interpretation.
4.R&D
2024: Development of DOCTOREYE X-EYE completed
2025: Regulatory and commercialization processes for DOCTOREYE X-EYE are currently underway
Approval from the Ministry of Food and Drug Safety (No. D 26-1)
Pie healthcare : AI software
DOCTOR EYE | X-EYE
DOCTOREYE X-EYE is an AI software solution that analyzes optical fundus images to detect the presence of ophthalmic diseases including age-related Macular degeneration, Diabetic retinopathy, Glaucoma, and Epiretinal membrane within seconds.
By doing so, it supports clinical decision-making by healthcare professionals.
*Approval from the Ministry of Food and Drug Safety (No. D 26-1)
Characteristic : X-EYE
1.EYE dieases
Macular degeneration
Diabetic retinopathy
Glaucoma
Epiretinal membrane
Macular degeneration
Macular degeneration
Diabetic retinopathy
Diabetic retinopathy
Glaucoma
Glaucoma
Epiretinal membrane
Epiretinal membrane
2.heat map
The system highlights key regions analyzed by the AI through heat map visualizations, enhancing interpretability for clinicians.
Macular degeneration
Macular degeneration
Macular degeneration
Macular degeneration
Glaucoma
Glaucoma
Glaucoma
Glaucoma
3.Report
To enable users to intuitively review examination results, the system provides the analysis results for easy interpretation.
4.Research and Development
2024: Development of DOCTOREYE X-EYE completed
2025: Regulatory and commercialization processes for DOCTOREYE X-EYE are currently underway
Approval from the Ministry of Food and Drug Safety (No. D 26-1)
Characteristic 01
1.EYE to BRAIN
DOCTOREYE X-BRAIN analyzes optical fundus images to identify potential brain diseases and clinically significant neurological findings, thereby supporting clinical decision-making by healthcare professionals.
(It also provides visual insights into the brain using AI 3D modeling.)
*DOCTOREYE X-BRAIN is currently under research and development.
Characteristic 02
2.Accessibility, Cost
A quick fundus scan makes brain condition analysis accessible and cost-effective, with shorter exam time compared to CT or MRI.
Characteristic 03
3.R&D
We are conducting clinical research in collaboration with healthcare professionals in Korea, utilizing fundus images and MRI data.
characteristic 01
1.EYE to BRAIN
DOCTOREYE X-BRAIN analyzes optical fundus images to identify potential brain diseases and clinically significant neurological findings, thereby supporting clinical decision-making by healthcare professionals.
(It also provides visual insights into the brain using AI 3D modeling.)
characteristic 02
2.Accessibility, Cost
A quick fundus scan makes brain condition analysis accessible and cost-effective, with shorter exam time compared to CT or MRI.
characteristic 03
3.R&D
We are conducting clinical research in collaboration with healthcare professionals in Korea, utilizing fundus images and MRI data.
*DOCTOREYE X-BRAIN is currently under research and development.
Characteristic 01
1.On device AI
RETVIEW100xDOCTOR EYE
The AI software DOCTOREYE X-EYE is planned to be integrated into the RETVIEW100 fundus camera.
Following image acquisition, the system can analyze fundus images within seconds to detect the presence of ophthalmic diseases including Diabetic retinopathy, age-related Macular degeneration, Glaucoma, and Epiretinal membrane thereby supporting clinical decision-making by healthcare professionals.
*On device AI is currently under R&D
Characteristic 02
2.Auto shot
With its automatic imaging capability, RETVIEW100 allows fundus imaging to be easily performed by medical staff without specialized ophthalmic training.
Auto Tracking
Auto Focusing
Auto Shot
characteristic 01
1.On device AI
RETVIEW100xDOCTOR EYE
The AI software DOCTOREYE X-EYE is planned to be integrated into the RETVIEW100 fundus camera.
Following image acquisition, the system can analyze fundus images within seconds to detect the presence of ophthalmic diseases including Diabetic retinopathy, age-related Macular degeneration, Glaucoma, and Epiretinal membrane thereby supporting clinical decision-making by healthcare professionals.
*On device AI is currently under R&D
characteristic 02
2.Auto shot
With its automatic imaging capability, RETVIEW100 allows fundus imaging to be easily performed by medical staff without specialized ophthalmic training.
Auto Tracking
Auto Focusing
Auto Shot
Achievements
IAAI registered
Registered in IAAI Track 2
Mr. Jeongwoo Park, Senior Researcher at Piehealthcare, presented a paper at an IEEE-hosted international conference on improving training-free zero-shot composed image retrieval (CIR).
Awards
Minister’s Award of the Ministry of SMEs and Startups (Korea)
Grand Prize (Top Award), 2025 SME Management Innovation Competition
2025 Suwon City Outstanding SME Entrepreneur Award
Grand Prize in the Management Innovation Category
Korea Innovators Community Summit
KOREA Frontier
Piehealthcare was selected as a Korea Frontier company and participated in the 2025 Korea Innovative Startup Summit. In addition, the company plans to engage in the World Economic Forum’s Innovators Communities over the next two years.
Achievements
IAAI registered
Registered in IAAI Track 2
Mr. Jeongwoo Park, Senior Researcher at Piehealthcare, presented a paper at an IEEE-hosted international conference on improving training-free zero-shot composed image retrieval (CIR).
Awards
Minister’s Award of the Ministry of SMEs and Startups (Korea)
Grand Prize (Top Award), 2025 SME Management Innovation Competition
2025 Suwon City Outstanding SME Entrepreneur Award
Grand Prize in the Management Innovation Category
Korea Innovators Community Summit
KOREA Frontier
Piehealthcare was selected as a Korea Frontier company and participated in the 2025 Korea Innovative Startup Summit. In addition, the company plans to engage in the World Economic Forum’s Innovators Communities over the next two years.
Project
DOCTOR EYE
Leadership Group
Project
DOCTOR EYE
Leadership Group
Education
B.S. in Biotechnology, Catholic University
Training & Activities
Seoul Nat’l Univ. AI CEO Program
Chairman, Suwon Venture Business Association
Awards
Minister’s Prize, SME Innovation Challenge
Experience
Sales & Marketing, Hanmi Pharm (2011–2017)
Ranked #1 nationwide in Hospital Division for 4 consecutive years
Founded Piehealthcare in 2014, serving as CEO
Education
M.D., M.S., Ph.D. in Neuroscience, Seoul National University(SNU) College of Medicine
Experience
Professor of Neurology, SNU Hospital
Research at UCSF Encephalitis Center
Post-Doc, Harvard (Dana-Farber / Brigham & Women’s Cancer Center)
Former Associate & Assistant Professor, SNU Hospital
Clinical Fellow and Resident, SNU Hospital
Education
M.S. in Orthopedic Surgery, SNU
M.D., SNU College of Medicine
Experience
Director, Namyangju Baek Hospital
Orthopedic Specialist, SNU Hospital
Selected as Korea’s Top 100 Doctors (2020)
Former Director, Hwaseong Spine Center & Davos Spine Center
Former Head, BuMin Hospital Spine Center
Former COO, Synergy Hospital
Education
M.D., Ph.D., SNU College of Medicine
M.S., SNU College of Medicine
Experience
Board Member, Ewha Haktang Foundation
Former Minister of Health & Welfare (52nd)
Former Vice Director & Director, Bundang SNU Hospital
Former Professor, SNU College of Medicine
Education
M.D., Ph.D., SNU College of Medicine
M.S., SNU College of Medicine
Experience
Clinical Professor, SNU Hospital Healthcare System Gangnam Center
Head of Ophthalmology,
Sheikh Khalifa Specialty Hospital (UAE)
Former Associate Professor, SNU Hospital
Ophthalmology Specialist, SNU Hospital
Education
M.D., Ph.D., SNU College of Medicine
M.S., SNU College of Medicine
Experience
Professor of Neurology, SNU Hospital
Associate Professor, SNU Gangnam Center
Research Fellow, Massachusetts General Hospital, Harvard
Former Faculty, Inje Univ. College of Medicine
Specialist in Neurodegenerative Disorders, SNU Hospital
Education
Ph.D., Harvard University (Biostatistics)
M.S., Yale University (Biostatistics)
B.S., Ewha Womans University (Mathematics)
Experience
Assistant Professor, Data Science, Ewha Womans University
